Effects of cyclic AMP, sympathomimetic amines, and adrenergic receptor antagonists on renin secretion.
D000241:Adenosine / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001158:Arteries; D001794:Blood Pressure; D003404:Creatinine / Q000652:urine; D000242:Cyclic AMP / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004285:Dogs; D005919:Glomerular Filtration Rate; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007668:Kidney / Q000098:blood supply / Q000187:drug effects; D008012:Lidocaine / Q000494:pharmacology; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012039:Regional Blood Flow; D012083:Renin / Q000097:blood / Q000378:metabolism*; D012964:Sodium / Q000652:urine; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D014556:Urine / Q000502:physiology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D013566:Sympathomimetics; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D008012:Lidocaine; D012964:Sodium; D011433:Propranolol; D003404:Creatinine; D000242:Cyclic AMP; D012083:Renin; D000241:Adenosine; D007545:Isoproterenol; D009638:Norepinephrine; D010646:Phentolamine